CIK 0001098972
- Accelerated filer
- Smaller reporting company
AGENUS INC
Sign in to watch- Ticker
- AGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061562417
- Phone
- +1 781-674-4410
- Business address
- 3 FORBES ROAD, LEXINGTON, MA, 02421
- Former names
- ANTIGENICS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-17 | WIINBERG ULF Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | JORDAN WADIH Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | Jeynes-Ellis Allison M Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | Hirsch Susan B Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | Corvese Brian Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | CLARK PAUL N Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-12-17 | Kearns Evan VP and General Counsel | Grant or award · Stock Option (Right to buy) | +150,000 | 150,000 | ||
| 2020-12-17 | KLASKIN CHRISTINE M PFO and PAO | Grant or award · Stock Option (Right to buy) | +50,000 | 50,000 | ||
| 2020-12-17 | ARMEN GARO H Chairman and CEO | Grant or award · Stock Option (Right to buy) | +1,900,000 | 1,900,000 | ||
| 2020-12-17 | Buell Jennifer COO and President | Grant or award · Stock Option (Right to buy) | +900,000 | 900,000 | ||
| 2020-12-17 | Krauss Adam Chief Legal Officer | Grant or award · Stock Option, (Right to buy) | +50,000 | 50,000 | ||
| 2020-12-04 | ARMEN GARO H Chairman and CEO | Grant or award | +4,437 | $3.33 | $15K | 417,682 |
| 2020-11-25 | ARMEN GARO H Chairman and CEO | Gift | −31,100 | 704,046 | ||
| 2020-11-24 | ARMEN GARO H Chairman and CEO | Gift | −62,200 | 735,146 | ||
| 2020-11-20 | ARMEN GARO H Chairman and CEO | Grant or award | +4,049 | $3.65 | $15K | 412,645 |
| 2020-11-06 | ARMEN GARO H Director | Grant or award | +3,869 | $3.82 | $15K | 343,496 |
| 2020-10-23 | ARMEN GARO H Chairman and CEO | Grant or award | +3,751 | $3.94 | $15K | 339,627 |
| 2020-10-09 | ARMEN GARO H Chairman and CEO | Grant or award | +3,397 | $4.35 | $15K | 335,876 |
| 2020-10-08 | Hirsch Susan B Director | Grant or award · Stock Option (Right to buy) | +100,000 | 100,000 | ||
| 2020-10-01 | WIINBERG ULF Director | Grant or award · Deferred Stock Units | +6,464.58 | 90,282.56 |
Page 15 of 18 · 349 trades